SCHEMBL1089534

SCHEMBL1089534

c1ccc2c(N3CCCCCC3)nc(NCCCn3ccnc3)nc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.55
ALDH1A1 P00352 2/20 0.54
MRGPRX1 Q96LB2 1/20 0.54
GSK3A P49840 1/20 0.54
GSK3B P49841 1/20 0.54
NAMPT P43490 6/20 0.52
SOD1 P00441 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.50
TLR9 Q9NR96 1/20 0.49
TLR7 Q9NYK1 1/20 0.49
QPCT Q16769 1/20 0.49
MEN1 O00255 2/20 0.47
LMNA P02545 2/20 0.47
MAPT P10636 2/20 0.47
RECQL P46063 2/20 0.47
KMT2A Q03164 2/20 0.47
MAPK1 P28482 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1090384 1.00 SCN9A (0.55) SCN9AALDH1A1MRGPRX1GSK3AGSK3B
SCHEMBL1089693 1.00 SCN9A (0.55) SCN9AALDH1A1MRGPRX1GSK3AGSK3B
SCHEMBL1089224 0.99 SCN9A (0.55) SCN9AALDH1A1MRGPRX1GSK3AGSK3B
SCHEMBL1090942 0.85 SCN9A (0.51) SCN9AALDH1A1MRGPRX1GSK3AGSK3B
SCHEMBL1090472 0.83 HRH3 (0.65) ALDH1A1MRGPRX1SMN1; SMN2MEN1LMNA
SCHEMBL1088872 0.83 HRH3 (0.65) ALDH1A1MRGPRX1SMN1; SMN2MEN1LMNA
SCHEMBL1088939 0.83 HRH3 (0.65) ALDH1A1MRGPRX1SMN1; SMN2MEN1LMNA
SCHEMBL1090556 0.82 HRH3 (0.63) MRGPRX1TLR9TLR7MEN1LMNA
SCHEMBL1088592 0.79 KDM4E (0.63) ALDH1A1MRGPRX1SMN1; SMN2LMNAMAPT
SCHEMBL1088850 0.79 KDM4E (0.63) ALDH1A1MRGPRX1SMN1; SMN2LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 SCN9A 1243/4885ALDH1A1 916/4885MRGPRX1 237/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 SCN9A 1243/4885ALDH1A1 916/4885MRGPRX1 237/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 SCN9A 1243/4885ALDH1A1 916/4885MRGPRX1 237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.